Vinva Investment Management Ltd grew its position in shares of The Cigna Group (NYSE:CI – Free Report) by 2.2% in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 11,746 shares of the health services provider’s stock after purchasing an additional 248 shares during the quarter. Vinva Investment Management Ltd’s holdings in The Cigna Group were worth $4,084,000 as of its most recent SEC filing.
Other hedge funds and other institutional investors have also recently modified their holdings of the company. AQR Capital Management LLC increased its holdings in The Cigna Group by 63.4% in the second quarter. AQR Capital Management LLC now owns 1,547,245 shares of the health services provider’s stock worth $510,467,000 after purchasing an additional 600,215 shares in the last quarter. Ameriprise Financial Inc. increased its stake in shares of The Cigna Group by 23.4% in the 2nd quarter. Ameriprise Financial Inc. now owns 2,138,193 shares of the health services provider’s stock valued at $706,822,000 after acquiring an additional 405,694 shares in the last quarter. The Manufacturers Life Insurance Company lifted its position in shares of The Cigna Group by 145.3% during the 2nd quarter. The Manufacturers Life Insurance Company now owns 683,361 shares of the health services provider’s stock valued at $225,899,000 after acquiring an additional 404,791 shares during the period. International Assets Investment Management LLC boosted its stake in The Cigna Group by 49,287.7% during the third quarter. International Assets Investment Management LLC now owns 400,040 shares of the health services provider’s stock worth $138,590,000 after acquiring an additional 399,230 shares in the last quarter. Finally, Skandinaviska Enskilda Banken AB publ grew its holdings in The Cigna Group by 526.3% in the second quarter. Skandinaviska Enskilda Banken AB publ now owns 363,537 shares of the health services provider’s stock worth $120,174,000 after purchasing an additional 305,490 shares during the period. Institutional investors and hedge funds own 86.99% of the company’s stock.
Analysts Set New Price Targets
CI has been the topic of several research reports. Barclays upped their price objective on shares of The Cigna Group from $405.00 to $420.00 and gave the company an “overweight” rating in a report on Tuesday, November 5th. Jefferies Financial Group upped their price target on The Cigna Group from $402.00 to $422.00 and gave the stock a “buy” rating in a research note on Tuesday, September 17th. Piper Sandler reissued an “overweight” rating and issued a $394.00 price objective (up previously from $392.00) on shares of The Cigna Group in a research note on Tuesday, November 5th. StockNews.com lowered The Cigna Group from a “strong-buy” rating to a “buy” rating in a research report on Monday, November 4th. Finally, Royal Bank of Canada cut their target price on The Cigna Group from $384.00 to $377.00 and set an “outperform” rating on the stock in a report on Friday, November 1st. One investment analyst has rated the stock with a hold rating, fourteen have issued a buy rating and one has issued a strong buy rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Buy” and an average target price of $394.64.
The Cigna Group Stock Performance
Shares of CI stock opened at $336.50 on Friday. The company has a debt-to-equity ratio of 0.71, a current ratio of 0.72 and a quick ratio of 0.72. The firm has a 50-day moving average of $333.52 and a 200-day moving average of $338.51. The Cigna Group has a one year low of $253.95 and a one year high of $370.83. The company has a market cap of $93.60 billion, a P/E ratio of 31.75, a P/E/G ratio of 1.00 and a beta of 0.51.
The Cigna Group (NYSE:CI – Get Free Report) last posted its quarterly earnings data on Thursday, October 31st. The health services provider reported $7.51 EPS for the quarter, beating the consensus estimate of $7.22 by $0.29. The Cigna Group had a net margin of 1.31% and a return on equity of 18.42%. The firm had revenue of $63.70 billion during the quarter, compared to analyst estimates of $59.58 billion. During the same quarter last year, the business posted $6.77 EPS. The company’s revenue for the quarter was up 29.8% on a year-over-year basis. Equities research analysts forecast that The Cigna Group will post 28.5 EPS for the current fiscal year.
The Cigna Group Dividend Announcement
The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, December 19th. Shareholders of record on Wednesday, December 4th will be given a $1.40 dividend. The ex-dividend date of this dividend is Wednesday, December 4th. This represents a $5.60 annualized dividend and a yield of 1.66%. The Cigna Group’s dividend payout ratio is currently 52.83%.
About The Cigna Group
The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.
Featured Articles
- Five stocks we like better than The Cigna Group
- Short Selling: How to Short a Stock
- Eli Lilly, Pfizer, and AstraZeneca: 2025 Vaccine Makers to Watch
- Trading Halts Explained
- DICK’S Sporting Goods: The Under-the-Radar Buy-and-Hold Winner
- About the Markup Calculator
- 2 Cheap Quantum Computing Stocks to Buy Instead of Chasing IonQ
Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Cigna Group (NYSE:CI – Free Report).
Receive News & Ratings for The Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.